Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 1
2012 1
2013 1
2015 1
2016 1
2017 2
2018 6
2019 3
2020 2
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean tarik regard (9 results)?
Cancer Stem Cells and Targeting Strategies.
Barbato L, Bocchetti M, Di Biase A, Regad T. Barbato L, et al. Among authors: regad t. Cells. 2019 Aug 18;8(8):926. doi: 10.3390/cells8080926. Cells. 2019. PMID: 31426611 Free PMC article. Review.
Targeting cellular pathways in glioblastoma multiforme.
Pearson JRD, Regad T. Pearson JRD, et al. Among authors: regad t. Signal Transduct Target Ther. 2017 Sep 29;2:17040. doi: 10.1038/sigtrans.2017.40. eCollection 2017. Signal Transduct Target Ther. 2017. PMID: 29263927 Free PMC article. Review.
Long non-coding RNAs in cancer stem cells.
Schwerdtfeger M, Desiderio V, Kobold S, Regad T, Zappavigna S, Caraglia M. Schwerdtfeger M, et al. Among authors: regad t. Transl Oncol. 2021 Aug;14(8):101134. doi: 10.1016/j.tranon.2021.101134. Epub 2021 May 26. Transl Oncol. 2021. PMID: 34051619 Free PMC article. Review.
Targeting RTK Signaling Pathways in Cancer.
Regad T. Regad T. Cancers (Basel). 2015 Sep 3;7(3):1758-84. doi: 10.3390/cancers7030860. Cancers (Basel). 2015. PMID: 26404379 Free PMC article. Review.
PYK2 promotes HER2-positive breast cancer invasion.
Al-Juboori SI, Vadakekolathu J, Idri S, Wagner S, Zafeiris D, Pearson JR, Almshayakhchi R, Caraglia M, Desiderio V, Miles AK, Boocock DJ, Ball GR, Regad T. Al-Juboori SI, et al. Among authors: regad t. J Exp Clin Cancer Res. 2019 May 22;38(1):210. doi: 10.1186/s13046-019-1221-0. J Exp Clin Cancer Res. 2019. PMID: 31118051 Free PMC article.
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer.
Ferri C, Di Biase A, Bocchetti M, Zappavigna S, Wagner S, Le Vu P, Luce A, Cossu AM, Vadakekolathu J, Miles A, Boocock DJ, Robinson A, Schwerdtfeger M, Tirino V, Papaccio F, Caraglia M, Regad T, Desiderio V. Ferri C, et al. Among authors: regad t. J Exp Clin Cancer Res. 2022 Jan 11;41(1):20. doi: 10.1186/s13046-021-02233-w. J Exp Clin Cancer Res. 2022. PMID: 35016717 Free PMC article.
MTSS1 and SCAMP1 cooperate to prevent invasion in breast cancer.
Vadakekolathu J, Al-Juboori SIK, Johnson C, Schneider A, Buczek ME, Di Biase A, Pockley AG, Ball GR, Powe DG, Regad T. Vadakekolathu J, et al. Among authors: regad t. Cell Death Dis. 2018 Mar 1;9(3):344. doi: 10.1038/s41419-018-0364-9. Cell Death Dis. 2018. PMID: 29497041 Free PMC article.
23 results